Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells

被引:17
作者
Kang, HS
Lee, BS
Yang, Y
Park, CW
Ha, HJ
Pyun, KH
Choi, I
机构
[1] KIST, KOREA RES INST BIOSCI & BIOTECHNOL, MOLEC BIOMED RES GRP, TAEJON 305600, SOUTH KOREA
[2] CATHOLIC UNIV, COLL MED, BMT CTR, SEOUL 135, SOUTH KOREA
关键词
D O I
10.1006/cimm.1996.0064
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Deregulation of IL-6 production is one of the major causes for human multiple myeloma. Exogenous IL-6 stimulated the proliferation of fresh human myeloma cells and the myeloma cell line, U266, which produced IL-6 spontaneously, Anti-IL-6 antibody and IL-6 antisense oligonucleotide suppressed the IL-6-stimulated myeloma cell proliferation, indicating that IL-6 induced the myeloma cell proliferation via an autocrine loop. Okadaic acid, an inhibitor of protein phosphatase 1 and 2A, inhibited the U266 cell proliferation at a concentration of less than 1 ng/ml, At this concentration, okadaic acid suppressed the IL-6-induced IL-6 gene expression of myeloma cells. It seems that the okadaic acid blocked the myeloma cell proliferation by reducing IL-6 synthesis in myeloma cells. In addition, IL-6 itself also regulated IL-6 receptor expression, Analysis by FACScan and RT-PCR showed that anti-IL-6 antibody treatment up-regulated IL-6 receptor expression, Interestingly, the presence of okadaic acid induced the up-regulation of IL-6 receptor expression as well as the down-regulation of IL-6-induced gp130 phosphorylation in the myeloma cells, Taken together, these data suggest that protein phosphatase 1 and 2A are involved in IL-6-mediated autocrine growth of human myeloma cells by modulating IL-6 signaling and IL-6 receptor expression in myeloma cells. (C) 1996 Academic Press, Inc.
引用
收藏
页码:174 / 183
页数:10
相关论文
共 36 条
[1]   RECOMBINANT HUMAN B-CELL STIMULATORY FACTOR-II (BSF-2/IFN-BETA2) REGULATES BETA-FIBRINOGEN AND ALBUMIN MESSENGER-RNA LEVELS IN FAO-9 CELLS [J].
ANDUS, T ;
GEIGER, T ;
HIRANO, T ;
NORTHOFF, H ;
GANTER, U ;
BAUER, J ;
KISHIMOTO, T ;
HEINRICH, PC .
FEBS LETTERS, 1987, 221 (01) :18-22
[2]  
BARLOGIE B, 1989, BLOOD, V73, P865
[3]   REGULATION OF INTERLEUKIN-6 RECEPTOR EXPRESSION IN HUMAN-MONOCYTES AND HEPATOCYTES [J].
BAUER, J ;
LENGYEL, G ;
BAUER, TM ;
ACS, G ;
GEROK, W .
FEBS LETTERS, 1989, 249 (01) :27-30
[4]   BSF-2 IS NOT JUST A DIFFERENTIATION FACTOR [J].
BILLIAU, A .
NATURE, 1986, 324 (6096) :415-415
[5]  
BROWN RD, 1993, LEUKEMIA, V7, P221
[6]  
CALIGARISCAPPIO F, 1991, BLOOD, V77, P2688
[7]  
CHOI IP, 1994, J IMMUNOL, V152, P1532
[8]   OKADAIC ACID, AN INHIBITOR OF PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2A, INHIBITS INDUCTION OF ACUTE-PHASE PROTEINS BY INTERLEUKIN-6 ALONE OR IN COMBINATION WITH INTERLEUKIN-1 IN HUMAN HEPATOMA-CELL LINES [J].
GANAPATHI, MK .
BIOCHEMICAL JOURNAL, 1992, 284 :645-648
[9]   INTERFERON BETA-2/B-CELL STIMULATORY FACTOR TYPE-2 SHARES IDENTITY WITH MONOCYTE-DERIVED HEPATOCYTE-STIMULATING FACTOR AND REGULATES THE MAJOR ACUTE PHASE PROTEIN RESPONSE IN LIVER-CELLS [J].
GAULDIE, J ;
RICHARDS, C ;
HARNISH, D ;
LANSDORP, P ;
BAUMANN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) :7251-7255
[10]   STRUCTURAL-ANALYSIS OF THE SEQUENCE CODING FOR AN INDUCIBLE 26-KDA PROTEIN IN HUMAN-FIBROBLASTS [J].
HAEGEMAN, G ;
CONTENT, J ;
VOLCKAERT, G ;
DERYNCK, R ;
TAVERNIER, J ;
FIERS, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03) :625-632